LouisDSaravolatzMD

Infectious Disease • Grosse Pointe Woods, MI

Professor, Internal Medicine, Wayne State University School of Medicine

Join to view full profile

Dr. Saravolatz is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Saravolatz's full profile

Already have an account?

Office
19251 Mack Ave
Grosse Pointe Woods, MI 48236
Phone+1 313-343-7280

Fax+1 313-343-7921

Education & Training

Henry Ford Health/Henry Ford HospitalFellowship, Infectious Disease, 1977 - 1979
Henry Ford Health/Henry Ford HospitalResidency, Internal Medicine, 1974 - 1977
University of Michigan Medical SchoolClass of 1974

Certifications & Licensure

MI State Medical License 1975 - 2027
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Infectious Disease

Awards, Honors, & Recognition

Super Doctor SuperDoctors.com

Clinical Trials

The Addition of Indinavir to Anti-HIV Treatment in HIV-Infected Patients
Completed
Not Applicable
A Comparison of Zidovudine (AZT) Used Alone or in Combination With Didanosine (ddI) or Dideoxycytidine (ddC) in HIV-Infected Patients
Completed
Phase 3

Publications & Presentations

PubMed

1 citations
Rhodomyrtone: a new anti-agent against resistant strains.
Louis D Saravolatz, Joan Pawlak
JAC-Antimicrobial Resistance. 2024-08-01
3 citations
Determining if the prognostic nutritional index can predict outcomes in community acquired bacterial pneumonia.
Lisa De Rose, John Sorge, Brianna Blackwell, Mark Benjamin, Ayman Mohamed
Respiratory Medicine. 2024-05-01
Epidemiology, clinical features and outcomes of hospitalized patients with COVID-19 by vaccination status: a multicenter historical cohort study.
Shatha Alshanqeeti, Susan Szpunar, Premchand Anne, Louis Saravolatz, Ashish Bhargava
Virology Journal. 2024-03-21

Journal Articles

Delafloxacin: A New Anti-MRSA Fluoroquinolone
Louis Saravolatz, MD, Clinical Infectious Diseases

Press Mentions

Infectious Diseases Society of America Announces Next Editor-in-Chief of the Journal of Infectious DiseasesJanuary 11th, 2022
Why You Should Get the COVID-19 Vaccine, According to a Vaccine InvestigatorJuly 20th, 2021
Ascension St. John Hospital in Detroit Receives $2M for Infectious Disease ResearchNovember 4th, 2020
Join now to see all

Grant Support

Community Programs For Clinical Research On AIDSNational Institute Of Allergy And Infectious Diseases1994–1996
Community Programs For Clinical Research On AIDSNational Institute Of Allergy And Infectious Diseases1994–1995
Community Programs For Clinical Research AIDSNational Institute Of Allergy And Infectious Diseases1989–1993